MedTech News
Plexāā launches Bloom43 wearable breast surgery prep device
Plexāā announced that it launched its Bloom43 wearable preconditioning medical device for breast surgery in the U.S.
FDA approves IceCure cryoablation for breast cancer
IceCure Medical (Nasdaq:ICCM) announced today that the FDA granted marketing authorization for its ProSense cryoablation system for breast cancer.
Hologic gains FDA clearance for GI pathogen detection assays
Hologic’s FDA clearance for its Panther Fusion GI Bacterial and Expanded Bacterial Assays represents the company’s entry into the gastroenteritis test market.
LungCanSeek: New Blood Test Offers Affordable and Accurate Early Detection of Lung Cancer
SAN DIEGO, Oct. 1, 2025 /PRNewswire/ — A groundbreaking study published in Translational Lung Cancer Research reveals the potential of LungCanSeek, a novel blood test that uses four protein markers and artificial intelligence, to transform lung cancer screening by making early detection both highly effective and cost-efficient for broad populations, including those in low- and middle-income countries.
Introducing the ‘human repairome,’ a catalog of DNA ‘scars’ that may help define personalized cancer treatments
You can always be judged by your scars. This is the idea that sums up one of the new advances in basic and biomedical research published in the journal Science by the Spanish National Cancer Research Center (CNIO). It is the “human REPAIRome”—a name that refers to the repair of breaks in the DNA molecule.
Algae-based gel offers new tool for breast cancer research
In 2020, right when Jane Baude was starting her Ph.D. research at UC Santa Barbara, she learned that a critical component of her experiment—the gel needed to grow and test mammary epithelial cells—wouldn’t be available for nearly a year because of pandemic-related production issues. So, she and her advisor, professor Ryan Stowers, decided to pivot: Baude would engineer her own gel to study cells.
EndoQuest Robotics reports first gastroenterologist case in endoluminal robot trial
EndoQuest Robotics recently announced the completion of the first procedure performed by a gastroenterologist in its PARADIGM trial.
AI tool detects hidden warning signs of disease by analyzing genetic building blocks within cells
McGill University researchers have developed an artificial intelligence tool that can detect previously invisible disease markers inside single cells.